Skip to main content

Table 1 JFCR COMPARE analysis with KTC1101 as a seed

From: A novel pan-PI3K inhibitor KTC1101 synergizes with anti-PD-1 therapy by targeting tumor suppression and immune activation

Back to article page

Molecular Cancer

ISSN: 1476-4598